Why Oppenheimer Global fund is focusing on biotech as rates rise

Why Oppenheimer Global fund is focusing on biotech as rates rise


The recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks. Traders work on the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S., February 13, 2018.



from Biotech News